MultiSensor AI Holdings, Inc.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
MSAI$3.05-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(Amounts in thousands of U.S. dollars)
| | | | | | | |
|---|---|---|---|---|---|---|
| | Year Ended December 31, | |||||
| · · 2024 · · 2023 | ||||||
| Operating Activities · · | ||||||
| Net loss | | $(21,495) | | $(22,268) | ||
| Adjustments to reconcile net loss to net cash: (used in) provided by operating activities | | | | | ||
| Depreciation | | 1,140 | | 872 | ||
| Bad debt expenses | | 41 | | 194 | ||
| Inventory impairment | | 2,272 | | 1,689 | ||
| Non-cash lease expense | | 154 | | (26) | ||
| Deferred income tax expense (benefit) | | 62 | | (72) | ||
| Share-based compensation | | 3,382 | | 14,061 | ||
| Non-cash PIK interest | | — | | 30 | ||
| Other (income) expenses, net | | | 1,430 | | | — |
| Loss (Gain) on disposal of equipment | | | 322 | | | (18) |
| Loss on financing transaction | | 1,553 | | 4,043 | ||
| Change in fair value of warrants liabilities | | | (39) | | | (195) |
| Change in fair value of convertible notes | | 475 | | (970) | ||
| Increase (decrease) in cash resulting from changes in: | | | | | ||
| Trade accounts receivable | | 1,561 | | (928) | ||
| Deferred transaction costs | | — | | (1,098) | ||
| Inventories | | 256 | | 372 | ||
| Other current assets | | 68 | | 1,145 | ||
| Other noncurrent assets | | 3 | | — | ||
| Trade accounts payable | | (1,479) | | (14) | ||
| Income taxes payable | | (932) | | 480 | ||
| Contract liability | | (1,461) | | 1,657 | ||
| Other current liabilities | | 131 | | (110) | ||
| Right of use liabilities | | (159) | | (163) | ||
| Accrued expenses | | (2,814) | | (3,343) | ||
| Other noncurrent liabilities | | (38) | | 111 | ||
| Net cash used in operating activities | | (15,567) | | (4,551) | ||
| Investing Activities | | | | | ||
| Capital expenditures | | (2,667) | | (1,542) | ||
| Proceeds from sale of equipment | | | — | | | 30 |
| Net cash used in investing activities | | (2,667) | | (1,512) | ||
| Financing Activities | | | | | ||
| Proceeds from lines of credit | | — | | 1,547 | ||
| Repayments of lines of credit | | (622) | | (925) | ||
| Proceeds from promissory notes | | | — | | | 2,099 |
| Repayments of promissory notes | | | (575) | | | (100) |
| Proceeds from issuance of common stock | | | 22,726 | | | 6,287 |
| Proceeds from Equity Line of Credit issuances | | | 58 | | | — |
| Merger recapitalization | | — | | (2,344) | ||
| Net cash provided by financing activities | | 21,587 | | 6,564 | ||
| Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents | | 3,353 | | 501 | ||
| Cash, cash equivalents, and restricted cash equivalents beginning of year | | 1,155 | | 654 | ||
| Cash, cash equivalents, and restricted cash equivalents end of the year | | $4,508 | | $1,155 | ||
| | | | | | | |
| Reconciliation of cash, cash equivalents and restricted cash equivalents at end of period | | | | | | |
| Cash and cash equivalents | | | 4,358 | | | 1,155 |
| Restricted cash equivalents included in other current assets | | | 150 | | | — |
| Cash, cash equivalents, and restricted cash equivalents end of the year | | | 4,508 | | | 1,155 |
| | | | | | | |
| Supplemental cash flow information | | | | | ||
| Interest paid | | $63 | | $52 | ||
| Income taxes paid | | 2,331 | | 6 | ||
| | | | | | | |
| Non-cash investing and financing transactions | | | | | | |
| Conversion of promissory notes | | $— | | $18,501 | ||
| Conversion of convertible notes | | $6,170 | | $2,054 | ||
| Conversion of Legacy SMAP loan into common stock | | $200 | | $1,000 | ||
| Shares issued for Equity Line of Credit commitment fee | | $500 | | $1,324 | ||
| Inducement shares from Financing Transaction | | $1,381 | | $4,641 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.